Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 2006; 96(05): 690-691
DOI: 10.1160/TH06-08-0419
DOI: 10.1160/TH06-08-0419
Case Report
Pulmonary embolism associated with olanzapine
Further Information
Publication History
Received
01 August 2006
Accepted after revision
18 September 2006
Publication Date:
01 December 2017 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/200605/lookinside/thumbnails/10-1160-th06-08-0419-1.jpg)
-
References
- 1 White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107 (Suppl. 01) I4-18.
- 2 Piazza G, Goldhaber SZ. Acute pulmonary embolism: part I: epidemiology and diagnosis. Circulation 2006; 114: e28-e32.
- 3 Schoepf UJ, Kucher N, Kipfmueller F. et al. Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism. Circulation 2004; 110: 3276-80.
- 4 Scridon T, Scridon C, Skali H. et al. Prognostic significance of troponin elevation and right ventricular enlargement in acute pulmonary embolism. Am J Cardiol 2005; 96: 303-5.
- 5 Toki S, Morinobu S, Yoshino A. et al. A case of venous thromboembolism probably associated with hyperprolactinemia after the addition of olanzapine to typical antipsychotics. J Clin Psychiatry 2004; 65: 1576-7.
- 6 Zornberg GL, Jick H. Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet 2000; 356: 1219-23.
- 7 Walker AM, Lanza LL, Arellano F. et al. Mortality in current and former users of clozapine. Epidemiology 1997; 08: 671-7.
- 8 Hagg S, Tatting P, Spigset O. Olanzapine and venous thromboembolism. Int Clin Psychopharmacol 2003; 18: 299-300.
- 9 Liperoti R, Pedone C, Lapane KL. et al. Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents. Arch Intern Med 2005; 165: 2677-82.
- 10 Boullin DJ, Woods HF, Grimes RP. et al. Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine. Br J Clin Pharmacol 1975; 02: 29-35.
- 11 Wallaschofski H, Eigenthaler M, Kiefer M. et al. Hyperprolactinemia in patients on antipsychotic drugs causes ADP-stimulated platelet activation that might explain the increased risk for venous thromboembolism: pilot study. J Clin Psychopharmacol 2003; 23: 479-83.
- 12 Canoso RT, de Oliveira RM, Nixon RA. Neuroleptic-associated autoantibodies. A prevalence study. Biol Psychiatry 1990; 27: 863-70.
- 13 Hagg S, Spigset O, Soderstrom TG. Association of venous thromboembolism and clozapine. Lancet 2000; 355: 1155-6.
- 14 Naranjo CA, Busto U, Sellers EM. et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45.
- 15 Brandao LR, Williams S, Kahr WH. et al. Exerciseinduced deep vein thrombosis of the upper extremity. 1. Literature review. Acta Haematol 2006; 115: 214-20.
- 16 Arnone D, Hansen L, Davies G. Pulmonary embolism and severe depression. Am J Psychiatry 2002; 159: 873-4.
- 17 Hamanaka S, Kamijo Y, Nagai T. et al. Massive pulmonary thromboembolism demonstrated at necropsy in Japanese psychiatric patients treated with neuroleptics including atypical antipsychotics. Circ J 2004; 68: 850-2.